The study identifies MCI-specific gut mycobiome signatures and demonstrates how these signatures correlate with gut bacteria as well as with CSF AD biomarkers including the deposition of β-amyloid (Aβ)−40, Aβ−42 and total and phosphorylated tau. This evidence concerns the gene MAPT and Alzheimer disease.